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                                 ABSTRACT 
A STUDY ON NOSOCOMIAL INFECTION IN INTENSIVE MEDICAL CARE 
UNIT-INCIDENCE,PATTERN AND ETIOLOGY. 
R.RAMARAJ, FINAL YEAR POST GRADUATE,M.D.GENERAL 
MEDICINE,TIRUNELVELI MEDICAL COLLEGE HOPITAL,TIRUNELVELI. 
 
BAKGROUND: 
  Nosocomial infection is defined as an infection which develops 48 hours after 
admission to hospital and which was not incubating at the time of 
admission.The nosocomial infection results in increase in hospital stay 
time,increased morbidity and mortality.The aim of this study was to find the 
incidence,Etiology of nosocomial infection in intensive medical care unit in 
Tirunelveli medical college hospital.It was conducted in 200 patients from 
September 2012 to august 2013. 
METHODS: 
  All patients admitted in IMCU in Tirunelveli Medical college Hospital and 
stayed in the IMCU for more than 48 hours were included in the study.Data 
was included in a proforma and analysed using Epidemiological Information 
Package 2010 developed by Centre for disease control,Atlanta. 
RESULTS: 
 During the study period out of 200 patients 16 patients developed Nosocomial 
infection.So the incidence of Nosocomial infection was 8%.The most common 
Nosocomial infection was urinary tract infection(5.5%) followed by respiratory 
infection in 2% and blood stream infection in 0.5%.The most common 
organism causing Nosocomial infection was Klebsiella(5%),E.Coli(2%) and 
pseudomonas(1%). 
CONCLUSION: 
  Patients admitted in IMCU are at more risk for  developing nosocomial 
infection than in general wards.In our study Urinary tract infection was the 
commonest  followed by respiratory and blood stream infection.Gram negative 
organisms were the most common cause in this study. 
KEY WORDS: 
Nosocomial infection,Hospital acquired infection,Intensive care unit infection. 
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INTRODUCTION 
Nosocomial infection is defined as an infection which develops 48 
hours after hospital admission or within 48 hours after being discharged
[1,36]
 
and the infectious agent or toxin should not be incubating at the time of 
admission.The risk of nosocomial infection is 5 to 10 times higher in 
intensive medical care unit than in general wards
[5,38]
.The nosocomial 
infection is more common in elderly,immunosuppression,diabetics,renal 
failure,family members with MDR organisms
1
.  After admission, a patient's 
flora acquires the characteristics of  surrounding bacterial pool. Most 
infections which become clinically evident after 48 hours of hospitalization 
are  hospital-acquired. Infections which occur after the  discharge of the 
patient from the hospital is  healthcare-associated if the organisms were 
acquired during the hospital stay. 
Hospital-based programs of prevention,control and surveillance of 
nosocomial infections are in place since the 1950s.
[2] 
The Study on the 
Efficacy of Nosocomial Infection Control Project (SENIC) in 1970s showed 
that  nosocomial rates could be reduced by 32% if infection surveillance 
were coupled with appropriate infection control programs.
[3] 
In 2005, the 
National Healthcare Safety Network (NHSN) was started  in United states to 
integrate and succeed previous surveillance systems at the Centers for 
Disease Control and Prevention (CDC): National Nosocomial Infections 
Surveillance (NNIS), Dialysis Surveillance Network (DSN) and National 
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Surveillance System for Healthcare Workers (NaSH)
[4]
. Both developed and 
resource-poor countries are faced with the burden of healthcare-associated 
infections. In a World Health Organization (WHO) cooperative study (55 
hospitals in 14 countries from four WHO regions), about 8.7% of 
hospitalized patients had nosocomial infections.
[6]
 
A 6-year surveillance study from 2002-2007 involving intensive care 
units (ICUs) in Latin America, Asia, Africa, and Europe, using CDC's NNIS 
definitions, showed higher rates of central-line associated blood stream 
infections , ventilator associated pneumonias and catheter-associated urinary 
tract infections than those of comparable United States ICUs.
[7]
 
 
Patients are treated better in hospitals than in other places.But 
presence of a large number of patients under the same roof facilitate the 
spread of infection from one person to another. Infections in hospitals 
existed even in ancient times. Nosocomial infections in this era of powerful 
antibiotics still are important  consequence of hospitalization.A  minimum 
4% of patients are  discharged from the hospital after acquiring infections 
based  on  underlying  disease of the patient, hospital size and numerous 
other factors. Nosocomial infection places a huge burden on the patient and 
country.It prolongs the hospital stay of the patient.So it affects the economy 
of the patient’s family as the patient and his family members could not go to 
work. Indirectly it affects the productivity of the country. 
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The nosocomial infection can be prevented by maintaining asepsis in 
the concerned ward.Hand washing of the health personnel is the most 
important factor. In addition maintaining strict asepsis during urinary 
catheterization, during intubation, during insertion of vascular catheter is 
very important.   
In this study we want to find the incidence of nosocomial infection 
and the organisms causing it so that appropriate precautionary measures 
could be taken. Also the empirical antibiotics could be given to cover these 
organisms. 
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AIM OF THE STUDY 
 
1) To  find  incidence of Nosocomial infection in those  patients 
admitted in intensive medical care unit in Tirunelveli Medical college 
hospital. 
          2) To find the etiological agents in such infections. 
           3) To determine the incidence of specific type of nosocomial 
infection. 
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REVIEW OF LITERATURE 
DEFINITION 
The term nosocomial infection is now known as hospital acquired 
infection (HAI) and expanded to health care associated infections (HCAI). It 
includes infections acquired in institutions other than the acute-care facilities 
(e.g. nursing homes) during hospital stay but not diagnosed till discharge and 
through outpatient care such as day surgery, dialysis, or those on home 
parenteral therapy. It is defined as a disease condition resulting from the 
presence of an infectious agent or its toxin which was not present or 
incubating at the time of admission to hospital. Usually the infection 
becomes evident 48 hours or more after admission
1
. 
The common sites of infection are: 
 Respiratory tract 
 Blood stream 
 Urinary tract 
  Surgical site. 
HISTORICAL MILESTONES: 
 Egyptian papyrus written in 3000 B.C gives details of hospital related 
infections.The absence of data regarding hospital related infections 
before this period does not mean absence of infection before this 
period. 
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 In Ayurveda (600 B.C) there is detailed description about hospital 
acquired infections and how to prevent or minimize them. There is 
also description about segregation of infective patients from normal 
persons. 
 The great physician Charaka and pioneer of many surgeries Sushruta 
have written about the prevention of infection in clinical practice. 
 The  Herodatus records describe about  the conditions of hospitals in 
Rome and Greek in 1000 to 600 B.C give evidence about the 
infections. 
 Hippocrates in 400 B.C also mentioned about importance of hospital 
acquired infections and the means to prevent them. 
 For several centuries the westerners believed that the cause for the 
disease is  the contagion and disease may spread by wind and various  
air currents. 
It was found that certain  drugs had the ability  to  prevent or check the 
progress of infection. 
In 1856 Louis Pasteur found  that some bacteria was the reason for the 
fermentation of wine which can be prevented by  heating during which the 
microorganisms were killed.In 1864 he proved that many such micro-
organisms existed in the atmosphere.. In a famous  lecture to Acadimiede 
Medicine in 1873, Louis Pasteur said that  “If I had the honour of being a 
surgeon, not only would I use absolutely clean instruments, but after 
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cleaning my hands with the greatest care would only use sponges previously 
raised to a heat of 1300-1500 Fahrenheit. I would still have to fear germs 
suspended in the air, and surrounding the bed of the patient.” 
The presently famous work of Semmelweiss on causes for puerperal 
sepsis was not accepted during 1861. He found that puerperal sepsis was  
more common with  doctors who examined patients after doing autopsy. 
Semmelweiss proposed that morbid matter were transferred to the  hands of 
doctors   from cadavers or other patients.This  was responsible for the 
disease transmission. A drastic reduction in rate of infection was achieved by 
hand-washing with chlorinated lime. 
 Florence Nightingale noted in the book “Notes on Hospitals”-  
“It may seem a strange principle to enunciate as the very requirement 
in a Hospital that it should do the sick no harm.” 
 The real rate of mortality and morbidity in large city hospitals is 
higher for same type of diseases than in patients getting treatment out of the 
hospital. 
 
 Florence Nightingale did not accept  germ theory of disease. She gave 
guidelines regarding nursing care, design of the hospital and personal 
hygiene.  
In 1869 Simpson in his “The sequelae of amputation”  found that  in 
large city hospitals the incidence of  sepsis was more than in rural practice. 
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As per Lister’s theory of antisepsis wound packing of compound 
fracture by carbolic acid and sterilization of instruments,suture materials 
reduce the rate of infection. Decontamination of hands and is an important 
aseptic procedure.  
 Gustao Neubar introduced the use of protective mask and sterile gown 
during surgery in the year 1883.Halsted used rubber gloves during  surgery 
for the first time in 1890.Von Bergman introduced steam sterilisation in 
1896 .Use of the mask and gloves increased decreased infection rate during 
and after the surgery and improved the success rate of surgery. 
Flugge established that tuberculosis spread by aerial and droplet 
spread in 1897. Hutinel found the isolation technique of diphtheria and 
many other bacteria in 1894. 
In the 20
th
  century the prevention of infection during and after surgery 
by aseptic techniques gained importance and this was given more importance 
than the antibiotic use.. AdequateVentilation of the operation theatre was 
given paramount importance. 
THE ERA OF ANTIBIOTICS 
The discovery of penicillin reduced severe infection and sepsis caused 
by many bacteria including Staphylococcus aureus.Many streptococcal 
infections were prevented or treated effectively.So both severe infections and 
mild infections were mainly caused by staphylococcus.  
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Resistance to penicillin and other antibiotics emerged subsequently which 
resulted in severe infections and sepsis by S.Aureus.Air borne,dust borne 
mode of  spread of infection were studied.Spread of infection through the 
infected hand of hospital workers and relatives were also studied.  S.Aureus 
infections began to decrease due to the use of newer powerful and broad 
spectrum antibiotics.After the decrease in incidence of gram positive 
infections,infections due to gram-negative bacteria began to occur in more 
patients;Many outbreaks occurred due to the gram negative bacteria like 
Klebsiella and E.coli. Pseudomonas aeuroginosa also caused a lot of 
infctions particularly in hospitals.If a particular group of antibiotic is used 
regularly in a community then organisms which are resistant to that 
particular antibiotic began to emerge. 
 
The Burden 
The worldwide nosocomial infection rate ranges from 6% to 
15%.
[37]
In Asia it ranges from 4% to 48% of which 45% to 65% are lower 
respiratory tract infections. Highest prevalence occurs in intensive care units 
(ICUs), in acute surgical and orthopedic wards. In a surveillance conducted 
in 12 ICUs in India, the rate of HCAI was 4.9% and 9.6 per 1000 ICU days. 
Healthcare-associated infections result in excess length of stay, mortality and 
health care costs. In 2002 an estimated 1.7 million healthcare-associated 
infections occurred in the United States, resulting in 99,000 deaths.
[10] 
In 
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March 2009, the CDC released a report estimating overall annual direct 
medical costs of healthcare-associated infections that ranged from $28-45 
billion.
[11]
Nosocomial infections occur in both adult and pediatric patients. 
Bloodstream infections, followed by pneumonia and urinary tract infections 
are the most common nosocomial infections in children; Urinary tract 
infections are the most common healthcare-associated infections in 
adults.
[12] 
Among pediatric patients, children younger than 1 year, babies 
with extremely low birth weight (≤1000 g) and children in the PICU or 
NICU have higher rates of healthcare-associated infections.
[13,14]
 Ninety-one 
percent of bloodstream infections were in patients with central intravenous 
lines (CVL), 95% of pneumonia cases were in patients undergoing 
mechanical ventilation, and 77% of urinary tract infections were in patients 
with urinary tract catheters.
[12]
 
The commonest organisms were: 
 Pseudomonas  
 Acinetobacter 
 Staphylococcus aureus 
 Methicillin resistant S.Aureus (MRSA) 
 Enterobacteriaceae 
 Candida species 
 Enterococci  
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 Stenotrophomonas. 
Common Sources of Infection 
Causative organisms may be present on the skin, nose, mouth, 
gastrointestinal tract, or vagina of the patient. They may be acquired from 
external sources like health-care personnel, visitors, hospital equipments, 
medical devices, or the health-care environment. Most infections are of 
bacterial etiology, though fungal and viral infections may occur in 
immunosuppressed patients and those already on broad-spectrum antibiotics. 
HOSPITAL ACQUIRED PNEUMONIA (HAP) 
Definitions 
Pneumonia occurring 48 hours or more after admission and which was 
not incubating at the time of admission is HAP. Intubation and mechanical 
ventilation (MV) is associated with 20-fold increase in risk of developing 
pneumonia.  
Ventilator associated pneumonia (VAP) is pneumonia in a person who 
has a device to assist respiration through an endotracheal tube or 
tracheostomy tube for a period of at least 48 hours before the onset of 
infection. VAP represents 80% of episode of HAP. Mortality in VAP due to 
Pseudomonas and Staphylococcus is very high.  
Health care associated pneumonia (HCAP) 
[31]
 is defined as pneumonia in 
any patient with at least one of the following risk factors: 
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1. Hospitalization in an acute care hospital for >2 days within the last 90 
days. 
2. Residence in a nursing home or long-term care facility within the last 
90 days. 
3. Receive outpatient intravenous antibiotics or chemotherapy or home 
wound care in last 30 days. 
4. Attended a hospital clinic or haemodialysis clinic in the last 30 days. 
5. Has a family member with known multi-drug resistant pathogens. 
SYMPTOMS: 
1) Cough 
2) Breathlessness 
3) Sputum production 
4) Pleuritic chest pain 
5) Elevated body temperature. 
Symptoms can be absent or moderate in older patients. 
Chest X-ray may give clue to etiology: 
1) Interstitial pneumonia caused by intracellular pathogens. 
2) Lobar pneumonia may be caused by S.Pneumoniae. 
CXR allows for staging of severity according to localization and 
number of involved lobes. 
CXR also helps to detect complications: 
-Pleural effusion 
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-Cavitations 
-Acute respiratory distress syndrome 
CT scan: 
-Cavitations in Tuberculosis 
 -Halo or crescent sign in aspergillosis of neutropenia patients.  
 
Causative Organisms 
HCAP may be early onset, that is within 4 days of hospitalization or 
late onset, beyond 4 days.  
The organisms causing early infections are: 
Moraxella catarrhalis, 
Haemophilus influenza 
S.Pneumoniae 
Viruses 
Late onset HCAP are caused by: 
 Gram-negative bacteria  
 Staphylococcus aureus 
 Viruses  
 Yeasts 
 Fungi 
 Legionella  
                       
14 
 
  Pneumocystis carinii. 
 Late onset pathogens often are multi-drug resistant (MDR).
[33]
 Over 
80% of nosocomial pneumonias are caused by Gram-negative bacteria. Now 
Acinetobacter is the organism which is of great concern. 
In India, 38% of HAP are caused by Acinetobacter, Pseudomonas 
species(20%), Klebsiella pneumonia (23%) and MRSA (5%). Forty eight 
percent of VAP and 2.3% HAP are caused by MDR organisms (Table1), 
while 7.3% are ploymicrobial.
[34,35]
 In most ICUs, MRSA although present is 
not as big a problem as in the western world. 
 
Table 1: Risk Factors for Multidrug Resistant(MDR) Infections
[18] 
Regular dialysis 
Immunosuppression 
Heart disease 
Renal failure 
Hepatic failure 
High incidence of antibiotic resistance in the community 
Presence of a family member with MDR organism 
 
Table 2: Risk Factors for HAP and VAP 
[15,16] 
Male 
Elderly age 
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Pre-existing diseases-pulmonary, diabetes, dialysis 
Immuno suppression 
Presence of intubation 
Enteral feeding 
Mechanical ventilation 
Supine position 
APACHE II score > 15 
Previous use of antibiotic for > 2weeks 
Multi-organ failure 
Reintubation due to failed weaning 
Use of paralytics, sedative 
Length of ICU stay 
 Diagnosis of HAP or VAP is made in the presence of progressive 
radiographic infiltrates or pleural effusion and at least 2 of the 4 
clinical signs of infection –  
 Fever>380C, 
 Purulent secretions, 
 Leucocytosis or Leucopaenia, 
 Decreasing oxygenation. 
Blood cultures are rarely positive.Positive pleural effusion culture is 
considered as specific.However spread of infection to pleural space is rare. 
Analysis of lower respiratory secretion is the most commonly used technique 
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to find organisms causing pneumonia.Microscopy and culture of sputum or 
endotracheal aspirates are associated with a high percentage of false positive 
results because of colonization of upper respiratory tract or trachea -
bronchial tree. If culture of endotracheal secretions is sterile in a patient with 
no change in antimicrobial therapy within the last 72 hours Ventilator 
associated pneumonia can be ruled out with high probability. 
-Negative predictive value>90%. 
-Extra pulmonary infectious process must be evaluated. 
Management 
1. Identification of pulmonary infection is the first step. 
2. Appropriate culture is required.  
3. Semi-quantitative or quantitative cultures of lower respiratory tract 
should be performed if HAP or VAP is suspected. Endotracheal 
aspirates, bronchoalveloar lavage (BAL), protected specimen brush 
(PSB) are required to isolate organisms. A quantitative endotracheal 
culture or non-bronchoscopic BAL is more relevant in the Indian set-
up. Recent start or change of antibiotics in the preceding 24 to 72 
hours may give rise to false negative reports. 
4. A broad-spectrum antibiotic should be started at the earliest in all 
clinically unstable patients regardless of culture reports as delay is 
associated with increased mortality. Choice of empirical antibiotics is 
guided by the local data on risk factors, local prevalence of organisms 
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and resistance patterns. Broad spectrum antibiotics covering Gram-
negative and Gram-positive organisms are usually started. A re-
evaluation is done at 48 to 72 hours. Once culture sensitivity reports 
are available de-escalation may be done. 
 
A clinical pulmonary infection score (CPIS), based on temperature, total 
leukocyte count, chest radiographic findings, respiratory secretions, 
endotracheal aspirate cultures and oxygenation status has been developed to 
predict presence of VAP. If CPIS is less than 6 both at baseline and at 72 
hours, most clinicians would safely allow stopping antibiotics. 
Guidelines for initial empiric antibiotic treatment: 
 If no risk factors for MDR pathogens and early onset VAP 
(duration of hospitalization less than 5 days) we may give 
monotherapy or limited spectrum antibiotic. 
 In patients with late onset (>5 days) or with risk factors for 
MDR pathogens a broad spectrum antibiotic or a combination 
of antibiotics should be given. 
 Initial choice should take in to account: 
 Patient characteristics 
 Underlying diseases 
 Contraindications to certain antibiotics. 
       De-escalation strategy: 
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              Once the culture results are available change the broad spectrum 
antibiotic to a narrow spectrum to which the organism is susceptible. This 
prevents the development of resistance. 
 
 
Duration of therapy: 
If aminoglycosides are used treatment may be stopped after 7 days. No 
clear consensus has been reached as to the duration of antimicrobial therapy 
for ventilator-associated pneumonia (VAP). Many experts treat for 14-21 
days. However, shorter course of antibiotic therapy (about 1 wk) may be 
adequate therapy for some cases.
[17] 
Response to therapy: 
Improvement is usually apparent after 48 to 72 hours of antibiotic 
therapy. Fever and hypoxemia are the best indicators for monitoring 
treatment. 
 Temperature becomes less than 38. C or 
 Pao2/Fio2 becomes more than 250 within 72 hours of adequate 
treatment. 
BLOOD STREAM INFECTION (BSI) 
Epidemiology 
Primary blood stream infections are identified by growth of 
pathogenic bacteria or fungi (that are not related to another site of infection) 
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from one or more blood cultures. Skin contaminants like coagulase 
Staphylococcus or Diphtheroids are considered causative of BSI, if more 
than one blood culture is positive along with presence of systemic signs and 
symptoms of infection like fever, chills, and hypotension. An alternative 
focus of infection should be absent. 
CATHETER ASSOCIATED BLOOD STREAM INFECTIONS: 
Catheter associated blood stream infections (CABSI) is said to be 
present if fever occurs during and up to 48 hours after removal of central 
venous catheter or arterial catheter but diagnosis does not require growth of 
same organism from the blood and the catheter. 
Catheter related blood stream infection (CRBSI) 
Diagnosis of CRBSI requires growth of same organism quantitative or 
semi-quantitative from the blood as well as the catheter. 
 CRBSI is seen in 5% patients with indwelling vascular uncoated 
catheter and almost 2 to 5 infections per 1000 catheter days. All lines arterial 
or central venous are risky. The incidence of CRBSI increase with the 
duration of catheterization,
[26,27,28]
 number of ports, and number of 
manipulations. Mortality may be almost 8% in Staphylococcus aureus 
bacteraemia. Fever, hypotension, purulence at exit site, blocked lumen, all 
may herald CRBSI. BSI due to short peripheral intravenous catheters is very 
low but phlebitis is very common. Line removal should be considered if the 
line is no longer needed; if the infection is caused by S. 
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aureus, Candida species, or mycobacteria; if the patient is critically ill; if the 
bacteremia does not clear in 48-72 hours; if symptoms of bloodstream 
infection persist beyond 48-72 hours; and if noninfectious valvular heart 
disease, endocarditis, metastatic infection, or septic thrombophlebitis is 
present.
[17]
 
In a report from north India, incidence of CRBSI was 19.4%. 
Organisms causing nosocomial BSIs were Pseudomonas (33% episodes), 
and Acinetobacter, Escherichia coli, Candida species, coagulase-negative 
Staphylococci and S.Aureus. 
PATHOGENESIS: 
First step is the colonization of the catheter. For non-cuffed catheters 
skin insertion site is the source of colonization. For cuffed catheters lumen of 
the hub is the primary source of entry. Micro organisms are introduced via 
the hand of the medical personnel while manipulating the hub. Colonization 
is universal after insertion of a central venous catheter but is independent of 
catheter related infection. 
Second step in pathogenesis is the formation of biofilm of 
extracellular polysaccharide rich slimy material by organisms. It promotes 
adhesiveness of bacteria to the surface of the catheter. Also resists 
antibiotics. 
Femoral catheterization is associated with a higher rate of infection 
and thrombotic complications when compared to subclavian catheterization. 
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Transparent occlusive dressings produce a warm environment. So they 
are associated with a high rate of infection than gauze dressing of the 
catheter. 
Clinical manifestations: 
1) Local manifestations 
2) Systemic manifestations 
Local manifestations: 
 Erythema 
 Edema 
 Tenderness 
 Purulent discharge 
SYSTEMIC MANIFESTATIONS: 
 Fever and chills 
 Hypotension 
 Hyperventilation 
 Altered mental status 
 Nausea and vomiting 
 Abdominal pain 
 Diarrhea 
Exit site infection: 
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Purulent drainage from the catheter exit site or erythema, tenderness 
and swelling within 2 cm of the catheter exit site and colonization of the 
catheter if removed. 
Port-pocket infection: 
Erythema or necrosis of the skin or subcutaneous tissue either over or 
around the reservoir of the implanted catheter and colonization of the 
catheter if removed. 
Tunnel infection: 
Erythema, tenderness and induration of the tissues above the catheter 
and more than 2 cm from the exit site and colonization of the catheter if 
removed. 
Diagnosis 
BSI is identified by the growth of pathogenic bacteria or fungi (that 
are not related to another site of infection) from one or more blood cultures 
drawn from peripheral veins. At least two sets of blood cultures must be 
drawn in each instance. Three sets may be needed to establish continuous 
bacteraemia. 
Different methods of diagnosing CRBSI have been described. Some 
require removal of the catheter (qualitative, semi-quantitative and 
quantitative cultures) while some can be done while retaining the catheter in 
place(qualitative or quantitative blood cultures from catheter). The best 
method is to obtain paired blood cultures, one from the central catheter and 
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another from the peripheral venous blood and the different time to culture 
positivity is noted. If central line sample shows positivity 2 hours earlier than 
the peripheral culture, it is a CRBSI. 
 
CATHETER SPARING DIAGNOTIC METHODS: 
 Paired blood cultures simultaneously from the central vein and 
peripheral vein. 
 Both blood samples drawn less than 10 minutes apart with the 
same volume of blood. 
 CVL/PERIPHERALRATIO of CFU of 5:1 represents true 
infection. 
 Acridine orange cytospin technique: 
Positive test indicates presence of bacteria. It is a rapid 
diagnostic test. It takes only 30 minutes for this test. 
 Catheter-drawn quantitative blood culture is the method in which 
a single quantitative blood culture is drawn from central venous 
catheter. Cutoff of 100 CFU/ml establishes the diagnosis. Major 
drawback is that it cannot distinguish between CRBSI and high 
grade bacteremia.  
DIAGNOSTIC METHODS REQUIRING CATHETER REMOVAL: 
 Semi quantitative roll-plate catheter culture:  
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    It is the international reference diagnostic method. Consists of 
rolling a 3 to 5 cm  section of the distal tip of the central venous 
catheter over a agar plate.Cutoff of >15 CFU defines catheter 
colonization. 
 QUANTITATIVE CATHETER CULTURES: 
Involves flushing a catheter segment in a broth with a target of 
retrieving organisms from both surfaces of catheter. Threshold of 
>1000 CFU correlated best with colonization. 
 STAIN AND MICROSCOPY RAPID DIAGNOTIC 
TECHNIQUES: 
It includes staining the removed catheter segments and subsequent  
fields indicate colonization. 
Acridine orange staining is used for rapid diagnosis in which 
fluorescence is indicative of positivity. 
PREVENTIVE STRATEGY:  
 Central venous catheters should be used only if medically 
necessary and should be removed as early as possible. 
 Hand washing 
 Maximal sterile barriers during insertion. 
 Cutaneous antiseptics with chlorhexidine. 
 Avoidance of femoral site. 
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ANTIMICROBIAL CATHETER LOCK SOLUTIONS: 
It involves flushing catheter lumen and then filling with 2 to 3 ml of a 
combination of anti-coagulant and a anti-microbial agent. Dwell time varies 
between 20 to 24 hours. Not possible if catheter has to be used. It is used in 
catheters which have to be kept for more than 30 days. Combination of 
vancomycin and heparin with or without ciprofloxacin is used. Minocycline 
and EDTA can also be used. 
ANTIMICROBIAL IMPREGNATION OF CATHETERS: 
Consists of impregnation of outer or inner surface of catheters with 
antibiotics.Slow release of antimicrobials will prevent initial colonization 
and biofilm formation. Concern has been expressed regarding development 
of resistant organisms in these patients. 
Management 
Management includes: 
 Confirming the source of infection 
 Determining the choice of antimicrobials 
 Determining the duration of therapy 
 Deciding whether to remove the catheters 
Catheter should be removed if : 
 CRBSI is suspected 
  Purulence at the insertion site  
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 Haemodynamically  unstable 
 Organ dysfunction 
 Fungal sepsis  
 MDR organisms  
 Once the diagnosis is confirmed. 
Routine replacement over a guide wire is not recommended. Empirical 
antibiotics should be started in seriously ill patients according to the local 
microbiological flora and this may require a change according to the culture 
sensitivity reports. Duration of antibiotics is tailored according to the 
causative organism and by the presence or absence of any complication. 
Fungal sepsis should be considered in patients at risk like in those with prior 
antibiotic exposure, parenteral nutrition,
[29,30]
 abdominal surgeries, and 
immune compromised host. 
SURGICAL SITE INFECTION (SSI) 
Epidemiology 
In India incidence of postoperative infections in hospitals varies from 
10% to 25%. Wound infections affect nearly 20% of post-operative cases 
.These occur due to close contact of medical and paramedical staff with the 
patient at various stages of treatment. In a north Indian hospital, incidence of 
wound infection in post-operative elective surgeries ranged from 11% to 
70% due to S.Aureus and 30% due to E.Coli.
[19,20] 
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Surgical patients are at risk of infection for many reasons. Surgery is 
inherently invasive. It creates portal of entry in natural epithelial barriers for 
pathogens to invade the host. Surgical illness is immune suppressive 
(trauma, burns, malignant tumors).There may be therapeutic immune 
suppression following solid organ transplantation. 
During surgery patients may be given general anesthesia. These 
patients will have: 
 Period of reduced consciousness during emergence 
 Risk of pulmonary aspiration of gastric contents 
 Nosocomial pneumonia occurs more frequently among surgical 
patients than comparably ill medical patients. 
CONTROL OF BLOOD SUGAR: 
Hyperglycemia is deleterious to host immune function. Poor peri-
operative control of blood sugar increases the risk of infection and worsens 
outcome from sepsis. Blood sugar value >200 mg/dl any time on first 
postoperative day increases the risk of surgical site infection 4 times. Blood 
glucose level should be maintained below 140 mg/dl. Some studies show 
that it decreases the mortality by 20 to 40%.There is less incidence of 
nosocomial infection and less organ dysfunction. 
BLOOD TRANSFUSION: 
Blood transfusion increases the risk of infection. Transfusion exerts 
immunosuppressive efforts through: 
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 Presentation of leucocyte antigens. 
 Induction of shift to T-Helper 2 phenotype 
 Leucocytes depleted red blood cell transfusion does not decrease the 
risk of infection. 
Stored blood leads to loss of 2,3-diphospho glycerate and adenosine 
triphosphate.This leads to loss of membrane deformability.This causes 
disruption of nutrient blood flow and impaired oxygen offloading.Thus 
blood transfusion does not increase oxygen delivery to critically ill patients 
with sepsis.It may increase the risk of organ dysfunction. 
Table3: Factors Determining Nosocomial Wound Infection 
Factors related to surgical procedures: 
 Pre-operative shaving-1 day before operation,  
 Type of surgery 
  Anesthesia 
  Wound drains 
  Tissue damage 
  Blood loss 
Host factors: 
 Age  
 Immunity 
  Diabetes 
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  Nutrition 
  Obesity 
  Antibiotic. 
 
Diagnosis and Management 
Signs of wound infection are: 
 Local redness 
  Swelling 
  Wound discharge 
  Fever  
  In severe cases shock and organ dysfunction. 
Appropriate culture from wound, drain and blood should be sent and 
empirical antibiotics started. Prevention of SSI includes treating infections 
harboured by the host before surgery, good antiseptic precautions, and 
antibiotic prophylaxis within 1 hour of surgery, hair clipping rather removal 
and optimum post-operative care including good glycemic control. 
URINARY TRACT INFECTIONS (UTI) 
UTI’s in hospital are mostly due to urological manipulation or the 
presence of indwelling catheters. 
Risk for UTI is high in: 
 Female 
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 Diabetics 
 Elderly 
 Peripartum period  
 Prolonged Duration of catheterization. 
Catheter-Associated Urinary Tract infections (CAUTI) 
A diagnosis of CAUTI is confirmed when a patient meets one of the 
two criteria. The first is when a patient with a urinary catheter has one or 
more of the following symptoms with no other recognized cause: 
 Fever (temperature>380C),  
 Urgency or suprapubic tenderness with 
  Culture-positive urine showing more than 105 colony-forming 
units per ml, with no more than two microorganisms isolated.  
The second criterion is when a patient with a urinary catheter has at 
least two of the following criteria with no other recognized cause: 
 Positive dipstick analysis for leucocyte esterase or nitrate,  
 Pyuria (>10 leucocytes per ml of urine), 
  Organism seen on gram-stain or physician diagnosis of urinary 
tract infection. 
  In a report from India, 24% of nosocomial infections were due 
to UTI and all had indwelling catheters. In another study age 
and urinary catheterization were independent risk factors for 
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UTI.
[46]
 Commonest isolated pathogen is E.coli, others include 
Enterobacter, S.epidermidis, S.aureus, and Serratia. 
Pathophysiology: 
Except for distal urethra the urinary tract is normally sterile. 
Resistance to UTI is due to: 
Exposure to uropathogenic bacteria. 
Age 
Hormonal status 
Urine flow 
Insertion of a urinary catheter allows organisms to access the 
bladder.Catheter induces an inflammation in the urethra.Allows bacteria to 
ascend in space between urethral mucosa and catheter. 
Catheter allows formation of biofilm.It consists of adherent 
organisms,extracellular products,host components deposited on catheter 
surfaces.Biofilm protects organism from antimicrobials and host immune 
response. 
Ascending route of infection is common in women due to their short 
urethra. 
Internal route of infection through lumen of catheter is due to reflux of 
pathogens from drainage system in to bladder.It also occurs when the 
drainage system fails to close or with contamination of urine in the collecting 
bag. 
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MICROBIOLOGY: 
Common organisms which cause UTI are: 
 Escherichia coli 
 Pseudomonas aeuroginosa 
 Enterococci 
 Poly microbial infections in few cases (5 to 12%). 
In IMCU gram negative organisms cause more than 70% of cases. 
IMPACT OF UTI IN IMCU: 
Nosocomial UTI is responsible for significant morbidity to the 
patients. But the urinary tract is the source of sepsis in only 10 to 14% of 
cases far less than the lung. 
Urosepsis is inflammation of the upper urinary tract which causes 
seeding of the blood with bacteria which causes local and distant destruction 
of tissues. 
PREVENTION OF UTI: 
 Reducing the duration of catheterization is the most important step in 
prevention of UTI. 
 Indwelling catheters are to be used only when necessary 
  Sterile techniques are to be used during catheterization  
 Closed system of drainage is to be used 
  Samples must be taken aseptically  
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  Irrigation is to be avoided. 
URINARY DRAINAGE SYSTEM: 
 Maintenance of a closed drainage system is good method for 
prevention. 
 Hand washing should be performed immediately before and after any 
manipulation of the catheter site or apparatus. 
 If small volume of fresh urine is needed for investigation the distal end 
of the catheter or the sampling port should be cleaned with a 
disinfectant and urine should be aspirated with a clean syringe. 
 Large volumes of urine should be should be obtained aseptically from 
the drainage bag. 
 Unobstructed flow should be maintained. 
 Catheter and collection tube should be prevented from kinking. 
 Collecting bag should be emptied regularly using a separate collecting 
container for each patient. 
 Poorly functioning or obstructed catheter should be irrigated or 
replaced. 
 Collection bags should be kept below the level of the bladder. 
 Indwelling catheter should not be arbitrarily changed at fixed 
intervals. 
Types of urethral catheters: 
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 Silver alloy catheters reduce the incidence of symptomatic UTI. 
 Catheters coated with minocycline and rifampin or nitofurantoin 
reduces bacteriuria. 
 
Meatal care: 
Twice daily meatal care does not reduce rate of infection.Vesical 
irrigation with antibiotics is not recommended as it does not reduce infection 
rate.The organisms also become more resistant. 
Alternatives to urinary catheter: 
 Condom catheters 
 Suprapubic catheterization 
 Intermittent urethral catheterization. 
Suprapubic catheterization is advantageous as compared to 
indwelling catheters with respect to bacteriuria,recatheterisation 
and discomfort. 
Management: 
 Asymptomatic bacteriuria in catheterized patients is not to be treated. 
 Symptomatic UTI should be treated. 
 Antibiotics selected should have good tissue penetration,minimal side 
effects,shold attain high urinary levels. 
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 High urinary levels should be present for an adequate period to 
eliminate the organisms.Renal concentration of cephalosporins 
remained higher than minimal inhibitory concentration for the most 
common bacteria. B-lactam antibiotics have a low pka,poor lipid 
solubility and penetrate poorly in to prostate.Good penetration in to 
prostate tissue has been demonstrated with  
aminoglycosides,fluoroquinolones,sulfonamides,nitrofurantoin.Renal 
toxic drugs should be avoided. 
TREATMENT OF COMPLICATED UTI: 
 Antibiotics should be started within the first hour after taking 
culture samples. 
 Empirical therapy should include one or more antibiotics 
presumed to have activity against the presumed organism. 
 For septic shock a combination of b-lactam with anti-
pseudomonal activity and a fluoroquinolone should be used.  
 
TRACHEOBRONCHITIS 
It is a very common problem, characterized by at least 2 of the 4, 
namely fever, cough, new or increased sputum production, rhonchi, or 
wheezing and at least one of the following: positive culture obtained by deep 
tracheal aspire or bronchoscopy or positive antigen on respiratory secretions 
but without radiographic evidence of pneumonia. 
                       
36 
 
SINUSITIS 
This entity is often overlooked in febrile patients especially when 
nasogastric or nasotracheal tubes are present. Apart from imaging, aspiration 
of affected sinus is necessary to diagnose the causative organism. 
 
GASTROINTESTINAL INFECTIONS IN THE IMCU: 
 10 TO 30% of nososcomial diarrhea is due to clostridium 
difficile.Other causes are: 
 Antibiotics 
 Chemotherapeutic agents 
 Proton pump inhibitors 
 Tube feeding 
 Laxatives 
 Idiopathic  
Empirical treatment is advised in severe cases while lab tests are pending. 
Other pathogens are: 
 Rota virus 
 Noro virus 
 Salmonella species 
Diarrhea in immune-compromised host: 
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 They are at risk of developing opportunistic infections.Use of various 
chemotherapeutic agents and immune modulators also predispose to 
diarrhea.Organisms which cause diarrhea in this group are: 
 Clostridium difficile 
 Salmonella enterica 
 Noroo virus 
 Cryptosporidium 
 Isospora 
 Cyclospora 
 Cytomegalovirus 
 Mycobacterium avium intracellulare 
Rapid diagnostic tests: 
 Direct stool examination for ova,cysts,parasites 
 Stool test for clostridium difficile toxin 
 PCR test for cytomegalovirus,herpes virus 
 Stool and blood cultures 
If these tests do not provide specific diagnosis endoscopy and mucosal 
biopsy are done to find the etiology. 
CLOSTRIDIUM DIFFICILE ASSOCIATED DIARRHOEA (CDAD) 
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In hospitalized patients C.difficile is one of the most important causes 
of diarrhea. Illness ranges from mild watery stool to life-threatening colitis 
and toxic megacolon. 
The identifiable risk factors for this include previous antibiotic 
treatment chemotherapeutics, immune suppressives, surgery, exposure to 
gastric acid suppressants, low immunity and advanced age. Metronidazole 
and oral vancomycin are the drugs of choice. 
 
MANAGEMENT: 
 Correct dehydration. 
 Anti microbials 
Dehydration: 
Mild:  
3 to 5% loss in body weight.Patients have increased thirst and slightly 
dry mucous membrane.Treated with ORS 50 ml/kg  over first 2 to 4 hours. 
Moderate: 
6 to 9 % loss in body weight.Patients have loss of skin turgor,dry 
mucous membranes, tenting of skin.Treatment is with ORS 100 ml/kg over 
first 2 to 4 hours. 
Severe dehydration: 
>10% of loss in body weight. Patients have lethargy, altered 
consciousness, prolonged skin retraction time, cool extremities and 
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decreased capillary refill time. Treatment is with immediate IV fluid 
replacement with 20 ml/kg of ringers lactate solution to restore perfusion and 
mental status. Continue with 100 ml/kg ORS. 
Empirical antimicrobial treatment. 
PREVENTION AND CONTROL OF NOSOCOMIAL INFECTIONS 
A hospital infection control committee comprising of a senior 
microbiologist, intensivisit, physician and surgeon is essential to prevent and 
control HAI. A central sterile supply department (CSSD) should be involved 
in dealing with sterile equipment and stores. Periodic surveillance of 
infections is important. Microorganisms, sensitivity patterns, antibiotic use, 
outcomes, all must be audited. Antibiotic policy should be formulated and 
revised regularly for effective therapy. 
STRATEGIES TO BE ADOPTED TO COMBAT HCAI 
1. Environmental factors: 
 Adequate bed-space ratio 
 Identifying infected zones 
 Proper disposal of biomedical wastes in protocol containers 
 Ensure food hygiene 
 Routine checking of potable, dialysis water 
 Ventilation strategies for operating theatres, isolation areas 
for infected or immune compromised cases 
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2. Specific standard precautions for all patients in health care settings 
as recommended by Centers for Disease Control and Prevention:
[32]
 
 Hand hygiene[40] with alcohol based rubs is to be performed 
after examining each patient, before and after every 
procedure or handling patient’s body fluids. In suspected 
C.difficile infection hands are to be washed with soap and 
water. 
 Respiratory and cough etiquettes are to be followed. 
 Mask, eye protection or face shield is to be worn for 
procedures which might involve splashes. 
 N95 or higher masks for diseases transmitted by respiratory 
aerosols like tuberculosis, some viruses. 
 Gloves are to be used where recommended. Masks and 
gowns are to be worn while handling patients infected with 
Acinetobacter, MRSA or MDR pathogens. 
 Appropriate handling of soiled linen and equipment and 
disinfection of environmental surfaces. 
 Used needles are not to be bent, broken by hand or recapped. 
 For patient resuscitation, a mouthpiece, resuscitation bag are 
needed to prevent contact with oral secretions. 
                       
41 
 
 For injected medications, single dose vials are preferable to 
multiple dose vials. 
With the better availability of technology, India also faces the 
problems of HAI with its attendant emergence of MDR pathogens. As a 
consequence of these the outcome in the form of patient survival and cost of 
therapy is worrying. Strict infection control policies and judicious use of 
antibiotic will be the cornerstone of combating this problem. 
 
 
PREVIOUS STUDIES: 
1)Nosocomial infections in intensive care unit-Martin langer,Ida 
salvo,Massimo mussico. 
2)A Study on  incidence of nosocomial infections in a university hospital.-
L.Ortona, G.Federico,M.Fantoni.Study was carried in a 1800 bed hospital 
over 9 months period.Nosocomial infections were 6.5% per 100 
discharges.UTI was the most common.E.coli,proteus,klebsiella were the 
causative organisms.Catheterisation was the most important risk factor. 
3)Risk factors and outcome of nosocomial infections.-results of a matched 
case control study of ICU patients. April 1998. Emmanualegirou 
,FrancoisStephen,Ananovoara.Studied about the relation between underlying 
disease,severity of illness,therapeutic drugs and incidence of nosocomial 
infections.Mortality attributable to nosocomial infections was 44%. 
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4)Nosocomial blood stream infections in US hospitals-A prospective 
nationwide surveillance.24000 blood stream infections were recorded in 49 
hospitals over a 7 year period.Gram positive organisms were responsible for 
65% cases,gram negative organisms were responsible for 25% cases,fungi 
9.5%. 
5)Prospective incidence study of nosocomial infections in a paediatric 
intensive care unit—in 2003.PonsM,Serra M.15% patients had nosocomial 
infections.51% patients had bacteremia,19% patients had UTI,17% had 
respiratory infections.  
6)Study on the efficacy of nosocomial infection control(SENIC project) in 
1998 by Hughes M.Evaluated the nosocomial infection control programmes 
in US.32% of infections were preventable. 
6)Alexis M Elward, et al 55 - Washington – prospective study 2000 - rates, 
risk factors, and outcomes of ventilator-associated pneumonia in pediatric 
intensive care unit . The incidence of ventilator-associated pneumonia  was  
3.3% and  5.1%  in mechanically ventilated patients.  The most common 
organisms were  Pseudomonas aeruginosa (29.4%), Klebsiella pneumoniae 
(14.7%), Staphylococcus aureus (11.8%), yeast (8.8%), Haemophilus 
influenza (8.8%), Streptococcus pneumoniae (5.9%). Multiple factors were 
analysed for risk factors. 
Ventilator-associated pneumonia was associated with the following 
procedures: reintubation, tracheostomy, transfusion, transport out of the 
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PICU, the presence of a central line, multiple central venous catheters, 
Bronchoscopy. 
Patients with VAP had higher mortality rate (20% vs 7%) which 
approached statistical significance. 
7)Emad H. Ibrahim, et al 58 from Washington did a prospective cohort 
study identify the occurrence of ventilator-associated pneumonia in a 
community hospital, and to determine the risk factors for VAP and the 
influence of VAP on patient outcomes in a nonteaching institution. 
Eight hundred eighty patients received mechanical ventilation and 
comprised the study cohort. One hundred thirty-two patients (15.0%) who 
received mechanical ventilation acquired VAP during their ICU stay.Patients 
with VAP were also statistically more likely to require reintubation, 
tracheostomy, multiple central venous lines, and to receive treatment with 
histamine type-2 receptor antagonists or sucralfate.Newman CD.Catheter 
related blood stream infections in the paediatric intensive care unit. 2006 
8)GastmeierP,GeffersC,BrandtC. Effectiveness of a nation-wide 
nosocomial infection surveillance system for reducing nosocomial 
infections. 
9)IYAD I.AL RUN-Community acquired urinary tract infection causing 
microorganisms among paraplegic patients in Gaza.E.Coli was the most 
common organism causing community acquired UTI.Urogenic bladder and 
bladder catheterisation is the most common risk factor. 
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10)YUAN,YUAN-Incidence and factors associated with nosocomial 
infection in a intensive care unit of an urban hospital in china.The infection 
rate was 6.5%. 
11)Rahim baghei.2007.An epidemiological study of nosocomial infections 
in the patients admitted in the intensive care unit in the urmia imam reza 
hospital.The incidence of nosocomial infection was 8.5%.Most common 
infections were pneumonia,UTI.Most common organism causing pneumonia 
was pseudomonas aeuroginosa.Urinary tract infection was caused by E.Coli. 
12)Ritesh agarval -2005.Epidemiology,risk factors,outcome of nosocomial 
infections in a respiratory intensive care unit in North India.33% patients had 
infection.23% patients had pneumonia while 7.5% had bacteremia,1.5% had 
UTI.The most common organisms were Acinetobacter(34%),Pseudomonas 
aeuroginosa (23%),Escherichia coli(15%). 
13)Akash deep-2004-Clinical and microbiological profile of nosocomial 
infections in a paediatric intensive care unit.The rate of nosocomial 
infections was 27%.The incidence of urinary,respiratory,blood stream 
infections were 56%,34%,10%.Klebsiella was the most common organism. 
14)Mehta.A.-2007-Device associated Nosocomial infection rates in 
intensive care units in seven cities.Health care associated infection occurred 
in 9%.Blood stream associated infection occurred in 7.92 1000 ICU 
days.VAP occurred in 9 per 1000 ICU days.UTI occurred in 1.4 per 1000 
ICU days. 
                       
45 
 
15)Mohamed saleem-2012-Prevalence of nosocomial infections in surgical 
wards in a tertiary care hospital in lucknow.20% had nosocomial infection. 
Older patients had increased infection than younger age.Escherichia coli was 
the most common organism followed by staphylococcus and 
acinetobacter,pseudomonas aeuroginosa,klebsiella. 
16)Umesh.S.Kamat-2009-Epidemiology of hospital acquired Urinary tract 
infection in a medical college hospital in Goa.Overall infection rate was 8%. 
33% of catheterised patients had UTI. E.Coli, pseudomonas, klebsiella, 
candida were the organisms responsible. 
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STUDY JUSTIFICATION 
Almost all patients admitted in Intensive Medical Care Unit (IMCU) of our  
 
hospital is in critical condition. Many patients develop nosocomial  
 
infection. The causative agents and risk factors vary in each IMCU.  
 
Nosocomial infection increases morbidity and mortality in critically ill  
 
Patients. This increases the duration of stay, need for prolonged antibiotic   
 
administration and increased utilisation of hospital resources. Many studies  
 
on nosocomial infection had been done in western countries. There has been  
 
limited data from developing  countries especially India. There are no prior  
 
studies from our institute on nosocomial infection. Hence it was decided to  
 
study the incidence and etiological agents  of nosocomial  infection in our  
 
IMCU. The results of the study will be helpful in finding the etiological  
 
agents and help in formulating antibiotic policy for nosocomial infection.  
 
This can reduce irrational use of antibiotics and subsequently prevent  
 
colonisation of multidrug resistant organisms. 
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MATERIALS AND METHODS 
Materials and methods: 
Selection criterion: 
All patients admitted in IMCU in Tirunelveli medical college hospital 
for more than 48 hours. 
Total number of patients under study- 200 
Period of Study: 
All the patients admitted as inpatients in  Intensive medical care unit 
in Tirunelveli Medical College Hospital, during the period of  
September2012 – November 2013 were included in this study. 
STUDY DESIGN: 
Prospective study. 
Geographic distribution: 
Geographic distribution of the patients were predominantly from rural 
areas of Tirunelveli, Tenkasi, Tuticorin Districts. 
Exclusion criterion: 
 All patients admitted in IMCU for less than 48 hours. 
 Patients with evidence of sepsis at admission. 
 Patients with proven pre-existing infection. 
 
Limitation of the Study: 
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1. Repeated cultures could not be performed in IMCU as patients were 
shifted to medicine ward. 
Selection and study of this patients were done as mentioned in the 
proforma. 
 
METHODOLOGY: 
All the patients were asked a thorough and detailed history and 
general and systemic examination were done.Incidence,rate of infection, also 
known as cumulative incidence rate method, is to measure the frequency of 
new cases of nosocomial infections occurred in a given time. Since the 
measurement data and the method required are easy to be collected and 
calculated, it was widely used by many articles.
[21,22,23]
 However, the 
weakness of this method is that it does not consider the time of 
hospitalization as well as some other risk factors that would influence the 
incidence rate. As indicated by researches, the Nosocomial infection 
incidence rate was nearly zero in the first day of admission, significantly 
increased after 1 week’s stay, peaked during 4 to 7 weeks’ stay, then 
dropped as the time went on.
[24,25] 
 
After careful clinical examination of the patients all were submitted to the 
following investigations. 
I.BASIC LAB INVESTIGATIONS: 
                       
49 
 
a) Complete blood count. 
b) Blood-Sugar, Urea, Creatinine. 
c) Liver function tests 
d) Urine analysis. 
II. CULTURE 
 URINE 
 SPUTUM 
 BLOOD 
 STOOL 
All the culture samples were delivered to laboratory in a sterile manner 
immediately.   
III. CHEST X RAY. 
Collection of samples: 
URINE:  
10 to 20 ml of mid-stream urine was collected in a sterile, dry, clean, 
wide necked bottle by explaining to the patient to avoid contamination i.e a 
clean catch sample. The bottles were labelled with name, date and time of 
collection of sample. The sample was sent to the lab immediately and 
processed. 
From catheterized patients urine sample was collected by disinfecting 
the wall of catheter at its juncture with the drainage tube.Urine was aspirated 
from a sterile disposable syringe. 
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BLOOD: 
For blood culture the veni puncture site was washed with soap,rinsed 
with sterile water,cleaned with a swab of 70% alcohol and then dried.Blood 
was drawn with sterile 10 ml syringe and transferred to blood culture bottle 
containing thioglycate broth,tryptic soya broth and the bottles were gently 
rotated to ensure mixing of blood with the broth.The whole procedure is 
done in an aseptic manner to avoid contamination.Blood was drawn from 
two separate sites and two samples were sent.Catheter tip was also sent in a 
culture bottle.  
SPUTUM: 
Sputum was collected after the patient rinses his mouth with sterile 
distilled water to remove excessive saliva and food debris.The patients were 
asked to cough deeply and the expectorated sputum was collected in a 
sterilized screw capped open mouth containers.The suction material from the 
endotracheal tube was also collected in a sterile container and sent to the lab 
immediately. Endotracheal tube tip was also sent for culture.  
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RESULTS AND OBSERVATIONS 
 
Statistical analysis:  
The information collected regarding all the selected cases were 
recorded in a Master Chart. Data analysis was done with the help of 
computer using Epidemiological Information Package (EPI 2010) 
developed by Centre for Disease Control, Atlanta.  
 Using this software range, frequencies, percentages, means, standard 
deviations, chi square and 
 'p'  values were calculated. Yate’s corrected chi 
square test was used to test the significance of difference between qualitative 
variables. A 'p' value less than 0.05 is taken to denote significant 
relationship. 
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          RESULTS AND OBSERVATION 
I. Relation between age and infection: 
The total number of patients included in the study was 200 during the 
period of 2012 – 2013 in Tirunelveli Medical College and Hospital. 
The Age and infection distributions were compiled in tabular columns 
as follows: 
 
Age group 
Cases 
No % 
Up to 20 years 19 9.5 
21-30 years 29 14.5 
31-40 years 26 13.0 
41-50 years 37 18.5 
51-60 years 45 22.5 
61-70 years 34 17.0 
>70 yrs 10 5.0 
Total 200 100 
Range 13 - 80 years 
Mean 46.0 years 
SD 17.3 years 
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The above table describes the number of patients admitted in relation 
with age of patient. The mean age of admission of patients in IMCU  was 46 
years.37% of patients were below 40 years of age and 63% of patients were 
above 40 years. 19 patients were below 20 years of age,29 patients were 
between 21 to 30 years of age,26 patients were between 31 to 40 years of 
age,37 patients were between 41 to 50 years of age,45 patients were between 
51 to 60 years age,34 patients were between 61 to 70 years and 10 patients 
were more than 70 years of age.The most number of patients admitted were 
in the age group of 51 to 60 years of age -22.5%.As in all medical wards old 
age people are admitted more than younger people in IMCU.This is because 
old age people have decreased immunity,associated diseases like 
diabetes,hypertension,Coronary heart disease,Carcinoma. Also they may be 
smokers and alcoholics.The rate of recovery is good in young patients 
compared to old age patients. Our study reveals that more patients were 
admitted to our hospital IMCU above 40 years of age than younger patients. 
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II Sex distribution 
The total number of patients included in the study was 200 during the 
period of 2012 – 2013 in Tirunelveli Medical College and Hospital.114 were 
male and 86 were female patients.The Age, Sex distributions were compiled 
in tabular column as follows: 
 
Sex Cases 
No % 
Male 114 57 
Female 86 43 
Total 200 100 
 
Total male patients were 114 and female patients were 86 in this 
study. 57% of the patients were male and 43% were female.More male 
patients are admitted in IMCU than female patients. 
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SIGNIFICANCE OF RISK FACTORS 
Diabetes mellitus and Nosocomial infection 
Out of the 200 patients in our study 30 patients had previous history of 
hypertension and 42 patients had previous history of diabetes out of which 
12 patients had both. 
Column1 Column2 
DIABETES 42 
HYPERTENSION 30 
BOTH 
DIABETES,HT 12 
TOTAL 
PATIENTS 200 
 
 
 
 
 
  
DM 
10% 
NON DM 
90% 
DIABETES MELLITUS AND 
NOSOCOMIAL INFECTION 
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RISK FACTOR 
NUMBER OF 
PATIENTS 
DM 4 
NON DM 38 
TOTAL 42 
 
Out of 42 diabetic patients 4 had nosocomial infection which is around 
10%. 
 
This picture shows that out of 16 patients with nosocomial infection 4 
were diabetic i.e 25% were diabetic. 
RISK FACTOR 
NUMBER OF 
PATIENTS 
DM 4 
NON DM 12 
TOTAL 16 
 
 
Diabetes 
25% 
Non diab 
75% 
DIABETES AND NOSOCOMIAL 
INFECTION 
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Relation between UTI and Diabetes Mellitus 
RISK FACTOR NUMBER OF PATIENTS 
DM 2 
NON DM 9 
TOTAL 11 
 
In our study there were 11 cases of Urinary tract nosocomial infection. 
Out of these only 2 patients were diabetic.This amounts to 18% of the 
patients with UTI. 
 
RISK FACTOR NUMBER OF PATIENTS 
DM 2 
NON DM 40 
TOTAL 42 
 
Out of 42 Diabetics only 2 patients had UTI.This is 5% of the  patients 
with UTI. 
DM 
18% 
NON DM 
82% 
UTI AND DM 
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Respiratory Nosocomial infection and Diabetes Mellitus. 
RISK FACTOR  
NUMBER OF 
PATIENTS 
DM 1 
NON DM 3 
TOTAL 4 
 
There were 4 patients out of 200 who had respiratory tract 
infection.Out of these 4 patients only one patient had Diabetes mellitus.So 
25% of the patients with respiratory infection  had Diabetes Mellitus.  
 
DM 
95% 
NON DM 
5% 
UTI AND DM 
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Respiratory infection and Diabetes mellitus. 
 
In this study  42 diabetic patients were admitted in IMCU.But only 
one had respiratory infection.This amounts to 2%. 
 
 
NUMBER OF 
PATIENTS 
25% 
NON DM 
75% 
RESPIRATORY INFECTION AND 
DIABETES MELLITUS 
RESPIRATORY 
INFECTION 
2% 
NO RESP 
INFECTION 
98% 
Chart Title 
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INFECTION 
NUMBER OF 
PATIENTS 
RESPIRATORY 
INFECTION 1 
NO RESP 
INFECTION 41 
TOTAL 42 
 
BLOOD STREAM INFECTION AND DIABETES MELLITUS 
 
 
 
 
Out of 42 diabetic patients only one had blood stream infection.This 
amounts to 2% of the infection. 
DM 
2% 
NON DM 
98% 
BLOOD INFECTION AND DM 
INFECTION NUMBER OF PATIENTS 
BLOOD INFECTION 1 
NO BLOOD INFECTION 41 
TOTAL 42 
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RISK FACTOR NUMBER OF PATIENTS 
DM 1 
NON DM 0 
TOTAL 1 
 
In this study only one patient had Blood stream infection who was a 
diabetic. 
 
 
 
 
INCIDENCE OF NOSOCOMIAL INFECTIONS 
 Table 3 : Incidence of Nosocomial infections 
DM 
100% 
NON DM 
0% 
BLOOD INFECTION AND DIABETES 
MELLITUS 
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Parameter Value 
Total ICU admissions during study period 200 
Number of nosocomial infections 16 
Incidence of nosocomial infection 8% 
  
 
Out of 20 patients 16 patients had nososcomial infection which  
amounts to incidence of 8%. 
 
 
 
Table 5 : Nosocomial infections as per various cultures 
NOSOCOMIAL 
INFECTION 
8% 
NO 
NOSOCOMIAL 
INFECTION 
92% 
INCIDENCE OF NOSOCOMIAL INFEC 
TION 
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11 patients had urinary tract  infection.4 patients had hospital acquired 
pneumonia and only 1 patient had  blood stream infection.5.5% patients had 
urinary infection,2% patients had sputum infection and 0.5% patients had 
blood infection. 
 
Culture  
Positive 
cases 
Negative cases 
No % No % 
Urine 11 5.5 189 94.5 
Sputum 4 2.0 196 98.0 
Blood 1 0.5 199 99.5 
Total 16 8.0 184 92.0 
‘p’ value between 
Urine & sputum 
culture 
Urine & blood 
Sputum & blood 
culture 
 
0.1143 Not significant 
0.0083 Significant 
0.1859 Not significant 
 
 
NOSOCOMICAL INFECTION AS PER VARIOUS 
CULTURES 
 
                       
66 
 
 
ORGANISMS IN CULTURES 
Urinary tract infection was caused by  Klebsiella in 6 patients,E.Coli 
in 4 patients and pseudomonas in 1 patient.Hospital acquired pneumonia was 
seen in 4 patients out of which 3 were due to klebsiella and 1 due to 
pseudomonas.Blood stream infection was seen in 1 patient only which was 
caused by klebsiella.5.5% patients had urinary tract infection,2% patients 
had hospital acquired pneumonia and only 0.5% patient had hospital 
acquired blood stream infection.The most common organism causing 
nosocomial infection is Klebsiella followed by E.Coli.  
ORGANISMS IN VARIOUS CULTURES 
189
11
196
4
199
1
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
URINE SPUTUM BLOOD
NEGATIVE POSITIVE
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Klebsiella caused 55% ,E.coli caused 36% and Pseudomonas caused 
9% of  UTI. 
KLEBSIELLA 
55% 
E.COLI 
36% 
PSEUDOMO
NAS 
9% 
UTI CAUSING ORGANISMS 
6 
4 
1 
3 
0 
1 1 
0 0 0 
1 
2 
3 
4 
5 
6 
URINE SPUTUM BLOOD 
Klebsiella Escherichia coli 
Pseudomonas  
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Table 4 : Organisms in various cultures 
Organisms Positive cases in 
Urine culture Sputum 
culture 
Blood Total 
No % No % No % No % 
Klebsiella 6 3.0 3 1.5 1 0.5 10 5.0 
Escherichia 
coli 
4 2.0 - - - - 4 2.0 
Pseudomonos 
Aeuroginosa 
 
1 
 
0.5 
 
1 
 
0.5 
 
- 
 
- 
 
2 
 
1.0 
Total positive 11 5.5 4 2.0 1 0.5 16 8.0 
Negative 189 94.5 196 98.0 199 99.5 184 92.0 
 
 
KLEBSIELLA 
75% 
E.COLI 
25% 
ORGNISMS CAUSING RESPIRATORY 
INFECTION 
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Table 6 : Nosocomial infections as per various organisms 
Organisms Positive cases Negative cases 
No % No % 
Klebsiella 10 5 190 95 
Escherichia coli 4 2 196 98 
Pseudomonos Aeuroginosa 2 1 198 99 
Total 16 8 184 92 
‘p’ value between 
Klebsiella and E.Coli 
Klebsiella and  Pseudomonas 
E.Coli and Pesudomonas 
 
0.1737 Not significant 
0.0402 Significant 
0.3426 Not significant 
 
KLEBSIELLA 
62% 
E.COLI 
25% 
PSEUDOMONAS 
13% 
ORGANISMS CAUSING NOSOCOMIAL 
INFECTION 
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10 patients had infection with Klebsiella, 4 had E.Coli infection and 
only 2 had infection with Pseudomonas.Klebsiella was responsible for 62% 
of hospital acquired infection,Escherichia coli was responsible for 25% of 
infections and pseudomonas aeuroginosa was responsible for 13% of 
infection. 
 
Age and Nosocomial infection 
TABLE 7 
 
Nosocomial infection 
Age in years 
Range Mean SD 
Positive 41 – 80 59.3 9.6 
Negative 13 – 79 44.9 17.3 
‘p’ 0.0011 Significant 
 
All 16 infections were seen in patients aged more than 40 years of 
age.None of the infection was seen in patients below 40 years of age.The 
mean age of the patient affected with Nosocomial infection was 59.3 
years.Age was a significant factor in the incidence of Nosocomial infection 
as per this study.The p value was 0.0011 which was highly significant. 
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SEX AND NOSOCOMIAL INFECTION 
 
0
10
20
30
40
50
60
POSITIVE NEGATIVE
59.3 
44.9 
M
e
a
n
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g
e
 (
y
e
a
rs
) 
NOSOCOMIAL INFECTION 
MEAN AGE
0%
20%
40%
60%
80%
100%
POSITIVE NEGATIVE
8 106 
8 
78 
NOSOCOMIAL INFECTION  
MALE FEMALE
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Sex and Nosocomial infection 
TABLE 8 
 
Sex 
Nosocomial infection 
Positive Negative 
No % No % 
Male (114) 8 7.0 106 93 
Female (86) 8 9.3 78 90.7 
‘p’ 0.7441 Not significant 
 
There was equal distribution of infection between male and female 
patients.8 male and 8 female patients had nosocomial infection.Male patients 
were affected in 7% cases and female patients in 9.3% cases.There was no 
statistically significant difference in infection between both sex. 
 
 
MALE 
45% 
FEMALE 
55% 
UTI IN BOTH SEX 
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UTI was present in 6 females and 5 males.So the UTI was seen in 
55% of females and 45% of males.So there was no significant difference in 
UTI between male and female. 
RESPIRATORY INFECTION IN BOTH SEX 
Respiratory infection was seen in 4 patients of which 3 were male and 
only one female.But the significance of difference between both sex could 
not be ascertained as the total number of patients with respiratory infection is 
less. 
 
 
RELATION BETWEEN FEVER AND NOSOCOMIAL 
INFECTION. 
 
All the 16 patients with nosocomial infection developed fever. So 
100% of patients with Nosocomial infection developed fever. 
MALE 
75% 
FEMALE 
25% 
RESPIRATORY INFECTION AND SEX 
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 CONSOLIDATION IN CHEST XRAY AND RESPIRATORY 
NOSOCOMIAL INFECTION  
All 4 patients with Respiratory Nosocomial infection had 
consolidation in CXR. 
 
 
 
 
FEVER 
100% 
NO FEVER 
0% 
FEVER 
0
0.5
1
1.5
2
2.5
3
3.5
4
CONSOLIDATION NO CONSOLIDATION
Series1
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RELATION BETWEEN LEUCOCYTOSIS AND 
NOSOCOMIAL INFECTION. 
 
 
 
 
 
 
 
 
 
 
 
 
 
All 16 patients with Nosocomial infection had Leucocytosis. 
 
 
 
 
 
 
 
 
 
 
 
LEUCOCYTOSIS
NO LEUCOCYTOSIS
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  DISCUSSION 
 
The incidence of Nosocomial infection in this study is 8%.The 
commonest infection was Urinary tract infection followed by respiratory 
tract infection and blood stream infection. Klebsiella was the most common 
organism followed by Escherichia coli and  pseudomonas aeuroginosa. 
Urinary tract infection was caused mostly by Klebsiella and Escherichia coli 
and pseudomonas. Respiratory infection was caused by Klebsiella and 
pseudomonas.Blood stream infection was caused by Klebsiella.  
The age of patients admitted in IMCU was between 13 years and 85  
years.Most patients were above 40 years of age i.e 63% of patients.The most 
comon age group was between 40 to 50 years i.e 22.5%.All nosocomial 
infections were in patients above 40 years old and it is statistically 
significant.In this study age had a significant relation to Nosocomial 
infection. 
In this study nosocomial infection was equally distributed between 
male and female.There was no statistically significant correlation between 
sex and Nosocomial infection. 
In this study out of the 16 patients with nosocomial infection 4 had 
diabetes mellitus i.e. 25% of the patients with nosocomial infection had 
diabetes mellitus.Urinary tract infection was seen in 2 diabetics and 9 non- 
diabeticsi.e 18% were diabetic and  the remaining 82% were non diabetic. 
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Out of the 4 patients with respiratory infection one was a diabetic i.e 25% 
were diabetic and 75% non diabetic. Blood stream infection was seen in only 
one patient who was diabetic. 
Relation with the AIM of the study: 
The results in this study falls within the average range of infection in 
India.As per this study Urinary tract infection is the commonest nosocomial 
infection in Intensive Medical Care Unit.Diabetes mellitus is seen in 25% of 
patients with Nosocomial infection But out of 42 patients with diabetes only 
4 had Nosocomial infection which was 10% only. 
LIMITATIONS AND STRENTHS: 
This study has some limitations.All patients admitted in IMCU could 
not be included in the study because most of the patients were shifted out of 
the IMCU before 48 hours of admission.Sample could be obtained only one 
time as most of the patients were shifted to the medical ward from 
IMCU.Empirical antibiotics were given to all patients admitted in our 
IMCU.This is the reason for low incidence of Nosocomial infection in our 
study.The relation between duration of stay in IMCU and the incidence 
could not be calculated. 
The sample size in this study is 200 which is relatively  a large 
sample.The study was conducted thought the year.So there is less chance for 
seasonal variation in this study. 
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Comparison with Other studies: 
Patients in IMCU are critically ill and they are more susceptible to 
nosocomial infection.They need invasive procedures and are in frequent 
contact with the health-care workers.They have disruption of barriers to 
infection due to endotracheal intubation,tracheostomy,urinary bladder 
catheterization,central venous catheterization.
[39]
So patients may get highly 
resistant infections. 
As per previous studies the most common nosocomial infection in 
medical ICU is urinary tract infection, pneumonia and blood stream 
infection.
[41]
Urinary tract infection was the commonest infection in our 
study.The source of urinary tract infection was placement of Foleys catheter. 
Richards and co reported in the national nosocomial infections 
surveillance system(NNIS) that 20 to 30% of nososcomial infections were 
due to urinary tract infection.
[41,42,43]
Roser and colleagues suggested that 
age(>50 years) and catheterization were independent risk factors for the 
development of urinary tract infection. Finkelstein and co reported an 
incidence of 10 to 14% in 337 patients in a single Israeli ICU.
[45] 
In our study urinary tract infection was 5.5%.Of these all patients were 
more than 40 years old.So there is a significant correlation between age and 
UTI.Out of the 11 patients with UTI 2 patients were known diabetic and 9 
were non diabetic.In previous studies diabetic patients have slightly higher 
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incidence of UTI than nondiabetic patients. In our study the number of 
diabetic patients having UTI are less due to starting empirical antibiotics on 
the day of admission itself, following aseptic care during catheterization and 
following the correct precautions to prevent infection. 
As per previous studies Nosocomial pneumonia is the second most 
common cause of nosocomial infection in ICU.It is the most common cause 
of death from infection acquired in hospital.
[47]
More than 90% of patients of 
nosocomial pneumonia occur in patients  on mechanical ventilation.More 
than 50% of ventilator associated pneumonia cases occur within first 4 days 
after intubation.
[48]
Frequency of pneumonia was between  2 to 25% in 
different studies.
[49]
In our study the incidence of pneumonia is 2%.Klebsiella 
was the cause in 3 cases and pseudomonas was the cause in 1 case.The low 
incidence of pneumonia in this study may be due to use of empirical 
antibiotics,use of antiseptic procedures during intubation , Good hand 
hygiene of hospital workers and regular suctioning of the endotracheal tube. 
                     Blood stream infection is a common nosocomial infection in 
IMCU. Central venous catheterization is the most common cause for the 
infection .In US more than 30000 deaths  annually are due to central venous 
catheterization.
[44]
As per study by Pfaller,Jones in united states and Canada 
Klebsiella was the most common organism.
[50]
Study by Marra,Wey also 
suggested that bloodstream infection with extended spectrum b-lactamase 
producing Klebsiella pneumonia affected the clinical outcome in patients 
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admitted in ICU.
[51]
In a prospective study in US in 24000 patients over a 7 
year period 65% of infections were due to gram positive organisms and 25% 
of infections were due to gram negative organisms. Incidence of Blood 
stream nosocomial infection in the present study is 0.5% only.This is due to 
use of empirical antibiotics,following  strict aseptic precautions during 
insertion and removal of catheters. 
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                              CONCLUSION 
 The incidence of nosocomial infection in patients admitted in  
 
Intensive Medical Care Unit was 8% in the study population.  
 
 The commonest infection was Urinary tract infection followed by  
 
respiratory tract infection and blood stream infection. 
 
 Gram negative bacteria especially Klebsiella was the predominant  
 
organism. 
 
 Age was a significant factor in this study.All patients who had  
 
Nosocomial infection were above 40 years old. Old age patients were  
 
more susceptible than young patients. 
 
  There was no significant difference in incidence between male and  
 
female patients. 
 
 
 
 
FUTURE STUDIES: 
The future studies on Nosocomial infection in our college Hospital may 
focus on:  
 Antibiotic resistance pattern among the causative agents for 
Nosocomial infection. 
 Correlation between duration of stay and incidence of infection. 
 Underlying Risk Factors. 
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   APPENDIX 
PROFORMA 
 
NAME:                            AGE:                     SEX:        
IP NUMBER:                      DATE OF ADMISSION: 
ADDRESS: 
CHIEF COMPLAINTS: 
H/O PRESENTING ILLNESS: 
In the past week has the patient received any 
antibiotic,steroids,immuno suppressants,H2 blockers. 
PAST HISTORY: 
HYPERTENSION,DIABETES MELLITUS,  
CHRONIC KIDNEY DISEASE,HIV,CARCINOMA 
IMMUNO SUPPRESSIVE DRUG INTAKE 
PERSONAL HISTORY: 
Smoking, Alcoholism, Drug abuse. 
GENERAL EXAMINATION: 
BP-                               PR-                  GCS- 
RR-                           SPO2-                 Temperature- 
SYSTEMIC EXAMINATION:       
CVS-               
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RS 
ABDOMEN- 
CNS- 
Provisional Diagnosis: 
 
INVESTIGATIONS: 
CBC- 
Blood Urea-                        Serum  Creatinine- 
Serum Electrolytes-                 
Urine sugar-                urine albumin-                    urine deposits- 
CXR 
BLOOD CULTURE: 
 
 
URINE CULTURE: 
 
SPUTUM CULTURE: 
 
STOOL CULTURE: 
 
THERAPEUTIC INTERVENTION IN IMCU: 
Urinary Catheterisation: 
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Dialysis: 
Endotracheal Intubation: 
Tracheostomy: 
Nasogastric tube: 
Blood Transfusion: 
DRUGS GIVEN: 
Immuno Suppressants: 
Steroids 
MASTER CHART 
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NAME AGE SEX IP Number URINE SPUTUM BLOOD HT DM FEVER WBC CXR
RAJIAH 65 M 66008 HT Y
RAMEESHA 47 F 65436
GURUVAMMAL 60 F 66019 E.COLI HT Fever L+
MARISELVI 39 F 65314
THAPPAN SINGH 24 M 65936
SHANMUGATHAI 65 F 66377 Y
KARPAGAVALLI 21 F 64034
MUTHU KUTTY 16 M 64411
VAIKUNDAN 70 M 65708 HT Y Fever L+
MADASAMY 28 M 66052
LAKSHMI 37 F 66357
BALAJI 15 M 60786
SUNDARAM 65 M 46463 Y
MOOKIAH 52 M 39255 Klebs HT Y Fever L+ CONS
VELU 58 M 66728
YESURAJ 25 M 66745
APPADURAI 40 M 66711
PANDARAM 65 M 66760 Y
ESAKKIAMMAL 70 F 66867 Y Fever L--
AHAMED 17 M 66883
MARIAPPAN 35 M 66876
RAJALAKSHMI 58 F 49614 Klebs Fever L+
ULAGAMMAL 75 F 67072 Y
KALLIAMMAL 43 F 67158  
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NAME AGE SEX IP NO URINE SPUTUM BLOOD HT DM FEVER WBC CXR
MUTHULAKSHMI 17 F 67258
UTCHIMAHALI 42 F 67247
MOOKAIYA 70 M 66626 Y
VALLI 50 F 67207
CHANDRAN 55 M 67318 HT
GNAMMAL 55 F 67324
MURUGAN 15 M 66070 Fever L--
ANNALAKSHMI 46 F 68086 HT
ARUMUGAM 55 M 67750 Y
DHADI VEERAN 34 M 65091
THIRUMALAIKUMAR 38 M 68101
SOWBEEDEN 24 M 68106
GANESAN 52 M 68085 Fever
ESAKIPANDIAN 79 M 68313 HT
MANISHA 13 F 68658
CHITIRAIKANI 28 F 68598
YOGALAKSHMI 13 F 68675
SUNDARAM 60 M 68724
PAPPATHI 60 F 68448 Y
VELDAS 60 M 68439 Klebs Fever L+ CONS
SRINIVASAN 67 M 68562 Y
CHITRA 54 F 68748 HT
VENKATESH 47 M 68863 Fever L+
BALAJI 59 M 69032 Y
KAVIYA 33 F 69135
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NAME AGE SEX IP NO URINE SPUTUM BLOOD HT DM FEVER WBC CXR
RADHA 26 F 69237
GAYATHRI 43 F 69383 Fever L+
TAMIL 55 M 69447
ALAGAMMAL 63 F 69542
ULAGAMMAL 67 F 69648 Klebs Fever L+
NAGARANI 47 F 69664
MANIKANDAN 42 M 69793
UNNAMALAI 37 F 69854
RAJESH 57 M 69877 Y
MANNAN 48 M 69894
VEERANARAYANAN 51 M 69921 Fever L+
DAMODHARAN 46 M 69937 HT
TIRUPATHI 57 M 69948 Y
KAMATCHI 54 M 69978
SARASWATHI 47 F 63189
KARTHIGA 24 F 64156
PATTANI 55 M 62780 Y
KARUNAKARAPANDIAN 60 M 67276 Klebsiella Fever L+
SUBBULAKSHMI 15 F 64523
LAKSHMANAN 61 M 66465 HT
BACKIYALAKSHMI 63 F 67134 Klebsiella Fever L+
SYED FATHIMA 47 F 66958
SUBRAMANIYAN 55 M 66861 Y
MOOKAIYA DEVAR 70 M 66626 HT
KASTHURI 60 F 66724 Y
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NAME AGE SEX IP Number URINE SPUTUM BLOOD HT DM FEVER WBC CXR
ALAGAMMAL 35 F 62696
BASKAR 40 M 67322
MARIA AROKIAM 64 F 68790 HT Y
RAJENDRAN 29 M 68677
CHELLADURAI 69 M 68336 HT DM Fever L+
MYDEEN 60 M 68164
MUTHU 18 M 68599
MUTHUKRISHNAN 28 M 68794
KANNAN 35 M 69375
SUDALAIMANI 25 M 69366
AYAPPAN 30 M 60507 Fever L+
NELLAI APPAN 36 M 69527
KARTHIKEYAN 26 M 69505
NITHYAKALYANI 22 F 64775
NANGAMUTHU 30 M 69525
SUBRAMANIAN 53 M 69478 E.COLI HT DM Fever L+
SHANTHI 25 F 69354
SUMITHA 54 F 67952 Y
NAGAPUTHIRAN 68 M 69912
MUTHULAKSHMI 53 F 69184 HT
SURESH 35 M 69992
GANESAN 49 M 71338
UCHIMAHALI 39 F 70435
ARUNACHALAM 65 F 66589 Pseudo Fever L+ CONS
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NAME AGE SEX IP NO URINE SPUTUM BLOOD HT DM FEVER WBC CXR
MUTHURANI 14 F 68586
SHANTHA 56 F 68498 HT
ESAKIAMMAL 17 F 68703
KANAGARAJ 78 F 67854 Fever L+
PATAMUTHU 60 M 68396 HT Y
INDIRA 62 F 68684
SELVI 35 F 68765
MUTHIAH DEVAR 72 M 68786 HT Fever L+
SANKARALINGAM 27 M 68864
CHARU 56 M 47564
RAMIAH 52 M 47654
SHEEBA 28 F 48652
IYAPPAN 47 M 49567
GURUNATHAN 63 M 49638 Fever
DEVAKI 33 F 50364
THENMOZHI 38 F 50377 Y
MUTHURAMALINGAM 50 M 50572 Klebsiella HT Fever L+
SELVI 55 F 50648 Y
AMARAVATHI 46 F 50776
RAMASAMY 64 M 51764 HT
MARIAPPAN 45 M 51879 Y
NACHIMUTHU 57 M 52372
NARAYANAN 49 M 52548
MURUGAN 62 M 54663 KLEBS HT Y Fever L+
AYISHA 43 F 54706 Y
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NAME AGE SEX IP NO URINE SPUTUM BLOOD HT DM Fever WBC CXR
SYED BEEVI 70 F 39899 Y
RAJA 48 M 39963
KANDASAMY 50 M 39972 Fever L+
GANESAN 32 M 40015
JAKIRA BANU 29 F 40035
RAJAIAH 44 M 40091 Y
IYAMPERUMAL 40 M 40097
MOOKAMMAL 75 F 40207 Y
MAHESWARI 21 F 40205
DEVADAS55 55 M 40282
SUDHA 13 F 40908
CHELLADURAI 73 M 43792 Fever L+
SUDALAIMUTHU 75 M 43656 Y
FATHIMA 65 F 49751 Y
MARIAMMAL 45 F 49763
SUNDARAM 65 M 46463 E.COLI Fever L+
MALAYANDI 54 M 46743
BALARAMAN 46 M 45436
RAJA 52 M 46589
MURUGESAN 39 M 46765
RAJALAKSHMI 44 F 46572 L+
KARUTHAMMAL 53 F 46689
VELAICHAMY 42 M 46754
PANDI 32 M 47462
PARVATHY 48 F 47489
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NAME AGE SEX IP NO URINE SPUTUM BLOOD HT DM FEVER WBC CXR
MARIAPPAN 40 M 27008 Y
THIRUNAVUKARASU 65 M 27033 Klebsiella Fever L+
SARASWATHY 20 F 27135
MOHAMED PUROSHITH 21 M 27147
MANICKAM 20 M 27166
KALIRAJ 36 M 27363
RAJAM 49 F 27371 HT
MARIAPPAN 35 M 27414
UCHIMAHALI 21 F 27428
MUTHULAKSHMI 40 F 27441 Y
SUDHA 13 F 27481
SUBBIAH 70 M 27466
THANGARAJ 60 M 27510 Y
GUNASINGH 52 M 27535 HT
DURAISAMY 25 M 27564 L+
VEERACHIAMMAL 21 F 27586
SYEDALI BADSHA 14 M 27605
AMANNULAH 48 M 39448
PETCHIAMMAL 52 M 39486 Fever
MUTHULAKSHMI 40 F 39592
ISAKKIAMMAL 19 F 39611
THIVYANADAR 62 M 39654
KANDASAMY 60 M 39693 Fever L+
GANESAN 47 M 39717
SELVASUNDARI 52 F 39776 Y
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NAME AGE SEX IP Numb URINE SPUTUM BLOOD HT DM FEVER WBC CXR
ANTHONY 54 M 25631 HT
CHELLAMAL 60 F 25620
SANKARAN 41 M 25656
SANKARAN 70 M 25686
JEGAJOTHI 56 M 25238
GANAPATHI 61 M 25898 HT
PITCHANDI 41 M 25930 Klebsiella Fever L+ CONS
MARISELVI 22 F 25946
CHELLAMAL 55 F 26003 HT Y
RANI 25 F 26162
PARVATHIAMMAL 80 F 26237 E.COLI Y Fever L+
UYKATTAN 70 M 25908 HT Y
NAGARAJ 45 M 26932
SUSEELA 50 F 26304 HT
PETCHIAMMAL 74 F 26281 Y Fever
SUDALI 46 F 26440
JOTHI 68 F 26402 Pseudo Fever L+
MOHAMED 26 M 26472
NAGARAJAN 45 M 26332
MANIMEKALAI 28 F 24515
INDU 19 F 26624
SELVARAJ 18 M 26719
SIVAPERUMAL 55 M 26746
SAKUNTHALA 62 F 26154 Y
KADARKARAI 75 M 26804 HT Y
 
 
ABBREVIATIONS/KEY TO MASTER CHART 
 
CKD-Chronic kidney disease 
HT-Hypertension 
DM-Diabetes Mellitus 
S.Aureus-Staphylococcus aureus 
E.Coli-Escherichia Coli 
Spp-Species 
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KLEBS-Klebsiella 
Pseudo-Pseudomonas aeuroginosa 
E.Coli-Escherichia coli 
IP NO-Inpatient Number 
L+ :Leucocytosis 
L- :Leucopenia 
CONS:Consolidation 
 
 
 
